Cargando…
Effect of combinations of antiviral drugs on herpes simplex encephalitis
2-Phenylamino-6-oxo-9-(4-hydroxybutyl)purine (HBPG) is a thymidine kinase inhibitor that prevents encephalitic death in mice caused by herpes simplex virus (HSV) types 1 and 2, although its potency is somewhat less than that of acyclovir (ACV). The present study was undertaken to determine the effec...
Autores principales: | Gebhardt, Bryan M, Focher, Federico, Eberle, Richard, Manikowski, Andrzej, Wright, George E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802127/ https://www.ncbi.nlm.nih.gov/pubmed/20054446 |
Ejemplares similares
-
When herpes simplex virus encephalitis meets antiviral innate immunity
por: Zhang, Linhai, et al.
Publicado: (2023) -
Tofacitinib Treatment in Primary Herpes Simplex Encephalitis Interferes With Antiviral Response
por: Krzyzowska, Malgorzata, et al.
Publicado: (2022) -
Treatment of Herpes Simplex Encephalitis
por: Illis, L. S., et al.
Publicado: (1972) -
An Unusual Presentation of Herpes Simplex Virus Encephalitis
por: Boyapati, Ray, et al.
Publicado: (2012) -
Normocellular CSF in herpes simplex encephalitis
por: Saraya, Abhinbhen W., et al.
Publicado: (2016)